Cargando…
A novel retinoic acid drug, EYE-502, inhibits choroidal neovascularization by targeting endothelial cells and pericytes
Choroidal neovascularization (CNV) occurs in neovascular age-related macular degeneration (AMD) and often leads to permanent visual impairment. Intravitreal injection of anti-vascular endothelial growth factor (VEGF) agents is the gold standard for the treatment of CNV. However, anti-VEGF treatment...
Autores principales: | Shen, Yaming, Xu, Miao, Ren, Ling, Li, Xiumiao, Han, Xiaoyan, Cao, Xin, Yao, Jin, Yan, Biao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10300120/ https://www.ncbi.nlm.nih.gov/pubmed/37369771 http://dx.doi.org/10.1038/s41598-023-37619-7 |
Ejemplares similares
-
EYE-503: A Novel Retinoic Acid Drug for Treating Retinal Neurodegeneration
por: Liu, Sha, et al.
Publicado: (2023) -
Long Non-Coding RNA PNKY Modulates the Development of Choroidal Neovascularization
por: Shi, Lianjun, et al.
Publicado: (2022) -
Choroidal Neovascularization: Mechanisms of Endothelial Dysfunction
por: Yeo, Natalie Jia Ying, et al.
Publicado: (2019) -
Association between choriocapillaris flow deficit and choroidal neovascularization activity in eyes with myopic choroidal neovascularization
por: Uematsu, Sato, et al.
Publicado: (2021) -
Aqueous Concentrations of Vascular Endothelial Growth Factor in Eyes with High Myopia with and without Choroidal Neovascularization
por: Wakabayashi, Taku, et al.
Publicado: (2013)